Navigation Links
No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
Date:9/21/2012

SACRAMENTO, Calif., Sept. 21, 2012 /PRNewswire/ -- According to new reports in the New York Times, BBC, Reuters and other publications, the authors of the highly controversial French study of rats and biotech foods forced reporters to sign non-disclosure agreements prohibiting journalists from validating the report's findings with independent scientists. Clearly, its authors were concerned that the now-debunked study would wilt under scientific scrutiny, which is exactly what has happened now that the report has been reviewed by independent scientific experts.

According to the BBC:

"In a move regarded as unusual by the media, the French research group refused to provide copies of the journal paper to reporters in advance of its publication, unless they signed non-disclosure agreements. The NDAs would have prevented the journalists from approaching third-party researchers for comment."

The New York Time's Dot Earth blog was even more blunt:

"I have to place it in a big bin of suspect studies "done by people out to prove something rather than investigate something," as the evolutionary biologist Michael Eisen said in a late update to my previous post on this work."

The Yes on Prop 37 campaign was coordinating with the French authors from the very beginning. In fact, within a few hours of the study release, Yes on 37 issued a media advisory announcing a press conference with the study's authors.

"It is clear that this so-called study is nothing more than a propaganda piece intended to create false fear and misinformation to help support the flawed Prop 37 campaign," said No on 37 campaign spokesperson Kathy Fairbanks. "After just a few hours of scrutiny, respected scientists and medical reviewers thoroughly discredited the study, its methodology and the authors.  Yes on 37 can't sell their flawed measure based on the facts, so they're forced to result to cheap tricks and junk science."

Paid for by No on 37: Coalition Against the Deceptive Food Labeling Scheme, sponsored by Farmers, Food Producers, and Grocers.  Major funding by Monsanto Company, E.I. DuPont de Nemours & Co., Grocery Manufacturers Association (GMA) and more than 40 food company members.  For a full list of donors visit www.NoProp37.com/donors. - 1-800-331-0850 - www.NoProp37.com

About Prop. 37
Proposition 37 would ban the sale of tens of thousands of perfectly-safe, common grocery products only in California unless they are specially repackaged, relabeled or remade with higher cost ingredients. Prop 37 is a deceptive, deeply flawed food labeling scheme that would add more government bureaucracy and taxpayer costs, create new frivolous lawsuits, and increase food costs by billions — without providing any health or safety benefits. That's why Prop 37 is opposed by a broad coalition of family farmers, scientists, doctors, business, labor, taxpayers and consumers.


'/>"/>
SOURCE No on Prop. 37
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genomic Health Announces Positive Topline Results of Large Prostate Cancer Clinical Validation Study; Company to Proceed with 2013 Commercial Launch
2. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
3. JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug
4. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
5. Science study shows promiscuous enzymes still prevalent in metabolism
6. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
7. Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty
8. University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity
9. SomaGenics Reports Study on Mechanism of Action of Its Therapeutic Platform
10. Cerulean Completes Enrollment of Randomized Phase 2 Study of CRLX101 in Non-Small Cell Lung Cancer
11. Sosei Announces Successful Completion of Phase I Study for SO-1105 for the Treatment of Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Bangkok, Thailand (PRWEB) , ... May 25, 2016 ... ... the participation of a Thai delegation at BIO 2016 in San Francisco. Located ... private sector will be available to answer questions and discuss the Thai biotechnology ...
(Date:5/25/2016)... ... May 25, 2016 , ... WEDI, the nation’s leading authority on the use ... W. Stellar has been named by the WEDI Board of Directors as WEDI’s president ... executive leader with more than 35 years of experience in healthcare, association management and ...
(Date:5/24/2016)... La Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... and financial planning for corporate executives and entrepreneurs, held The Future of San Diego ... leaders in the San Diego life science community attended the event with speakers Dr. ...
(Date:5/23/2016)... 23, 2016 Oxitec CEO Hadyn ... at 10:15 a.m. ET before the United States House Committee ... mosquitos can play in controlling the spread of the ... virus.      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) ... a self-limiting gene. Trials in Brazil , ...
Breaking Biology Technology:
(Date:3/15/2016)... New York , March 15, 2016 ... new market report published by Transparency Market Research "Digital Door ... Trends and Forecast 2015 - 2023," the global digital door ... US$ 731.9 Mn in 2014 and is forecast to grow ... 2023. Growth of micro, small and medium enterprises (MSMEs) across ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... http://www.apimages.com ) - --> - Renvoi : ... - --> --> ... solutions biométriques, fournit de nouveaux lecteurs d,empreintes digitales ... LF10 de DERMALOG sera utilisé pour produire des ...
(Date:3/10/2016)... -- --> --> ... Access Management Market by Component (Provisioning, Directory Services, Password ... Size, by Deployment, by Vertical, and by Region - ... is estimated to grow from USD 7.20 Billion in ... Compound Annual Growth Rate (CAGR) of 12.2% during the ...
Breaking Biology News(10 mins):